A biotech startup that’s backed by Silicon Valley’s well-known Y Combinator accelerator has ties to Baltimore: GEn1E Lifesciences is working to commercialize a treatment for inflammatory and age-related diseases that was developed at the University of Maryland, Baltimore, and is partnering with a Baltimore-based startup that also grew out of UMB collaboration.
Image: Dr. Ritu Lal is CEO of GEn1E Lifesciences. (Courtesy photo)
{iframe}https://technical.ly/baltimore/2019/12/04/gen1e-lifesciences-university-maryland-licenses-technology-y-combinator-backed-biotech-startup/{/iframe}